TrialAllergy2022

Phase 2a randomized clinical trial of dupilumab (anti-IL-4Rα) for alopecia areata patients.

Emma Guttman-Yassky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.